|
Re: What's up?
|
1
|
Resverlogix Corp.
|
May 25, 2023 10:02AM
|
|
Re: Trial Status
|
1
|
Resverlogix Corp.
|
Jul 22, 2021 10:08AM
|
|
Fun post
|
1
|
Resverlogix Corp.
|
May 22, 2015 12:25PM
|
|
Re: ZEN-3694 Single Agent Trial Status
|
1
|
Zenith Epigenetics
|
Sep 22, 2017 03:36PM
|
|
Re: ZEN-3694/Enzalutamid... vs. Enzalutamide alone?
|
1
|
Zenith Epigenetics
|
Apr 13, 2018 03:00PM
|
|
Re: Hopefully my email gets answered....
|
1
|
Resverlogix Corp.
|
Jun 06, 2017 10:47AM
|
|
Qatar Research overview of apabetalone
|
1
|
Resverlogix Corp.
|
Apr 23, 2024 08:41PM
|
|
Re: zenith trials
|
1
|
Zenith Epigenetics
|
Dec 10, 2022 12:31PM
|
|
Re: need more time, money & partners - FDA response may take until spring - pre market bid/ask..
|
1
|
Resverlogix Corp.
|
Dec 06, 2019 10:49AM
|
|
Financing
|
1
|
Resverlogix Corp.
|
Apr 26, 2024 11:18AM
|
|
Re: Update
|
1
|
Resverlogix Corp.
|
Feb 16, 2018 12:30PM
|
|
Re: Bloom Burton & Co Healthcare Conference
|
1
|
Resverlogix Corp.
|
Apr 19, 2018 04:03PM
|
|
Re: Seeing this kind of trading....
|
1
|
Resverlogix Corp.
|
Jul 17, 2015 08:03AM
|
|
Re: A bit of DD.
|
1
|
Resverlogix Corp.
|
Dec 10, 2021 01:08PM
|
|
Re: Resverlogix NYAS Symposium notes
|
1
|
Resverlogix Corp.
|
Apr 30, 2016 09:36AM
|
|
Re: Zenith prezzy
|
1
|
Zenith Epigenetics
|
Jun 21, 2017 12:55PM
|
|
Re: MERCK….
|
1
|
Resverlogix Corp.
|
Oct 02, 2021 10:47AM
|
|
Re: What Jardiance/EMPA-REG Outcome means for RVX-208
|
1
|
Resverlogix Corp.
|
Sep 17, 2015 03:28PM
|
|
Re: AGM - Jan 7, 2016 - Details
|
1
|
Zenith Epigenetics
|
Jan 14, 2016 10:03AM
|
|
Re: BET inhibitors RVX-208 and PFI-1 reactivate HIV-1 from latency
|
1
|
Resverlogix Corp.
|
Dec 05, 2017 05:46PM
|
